These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 8744272)
21. Inositol 1,3,4,5-tetrakisphosphate and regulation of intracellular calcium. Boynton AL; Dean NM; Hill TD Biochem Pharmacol; 1990 Nov; 40(9):1933-9. PubMed ID: 2242026 [No Abstract] [Full Text] [Related]
22. scyllo-inositol pentakisphosphate as an analogue of myo-inositol 1,3,4,5,6-pentakisphosphate: chemical synthesis, physicochemistry and biological applications. Riley AM; Trusselle M; Kuad P; Borkovec M; Cho J; Choi JH; Qian X; Shears SB; Spiess B; Potter BV Chembiochem; 2006 Jul; 7(7):1114-22. PubMed ID: 16755629 [TBL] [Abstract][Full Text] [Related]
23. Effects of L-690,488, a prodrug of the bisphosphonate inositol monophosphatase inhibitor L-690,330, on phosphatidylinositol cycle markers. Atack JR; Prior AM; Fletcher SR; Quirk K; McKernan R; Ragan CI J Pharmacol Exp Ther; 1994 Jul; 270(1):70-6. PubMed ID: 8035344 [TBL] [Abstract][Full Text] [Related]
24. Synthesis, calcium mobilizing, and physicochemical properties of D-chiro-inositol 1,3,4,6-tetrakisphosphate, a novel and potent ligand at the D-myo-inositol 1,4,5-trisphosphate receptor. Liu C; Davis RJ; Nahorski SR; Ballereau S; Spiess B; Potter BV J Med Chem; 1999 Jun; 42(11):1991-8. PubMed ID: 10354407 [TBL] [Abstract][Full Text] [Related]
25. Can enzymatic activity, or otherwise, be inferred from structural studies of annexin III? Perron B; Lewit-Bentley A; Geny B; Russo-Marie F J Biol Chem; 1997 Apr; 272(17):11321-6. PubMed ID: 9111038 [TBL] [Abstract][Full Text] [Related]
26. Cell signaling by a physiologically reversible inositol phosphate kinase/phosphatase. Shears SB; Yang L; Qian X Adv Enzyme Regul; 2004; 44():265-77. PubMed ID: 15581495 [No Abstract] [Full Text] [Related]
27. Ionization state of myo-inositol 1,4,5-trisphosphate: correlation with binding properties. Schmitt L; Schlewer G; Spiess B Biochim Biophys Acta; 1991 Oct; 1075(2):139-40. PubMed ID: 1657174 [TBL] [Abstract][Full Text] [Related]
28. Divergent syntheses of all possible optically active regioisomers of myo-inositol tris- and tetrakisphosphates. Chung SK; Kwon YU; Shin JH; Chang YT; Lee C; Shin BG; Kim KC; Kim MJ J Org Chem; 2002 Aug; 67(16):5626-37. PubMed ID: 12153261 [TBL] [Abstract][Full Text] [Related]
30. The inositol trisphosphate phosphomonoesterase of the human erythrocyte membrane. Downes CP; Mussat MC; Michell RH Biochem J; 1982 Apr; 203(1):169-77. PubMed ID: 6285891 [TBL] [Abstract][Full Text] [Related]
31. The preparation of D-myo-inositol 1,4-bisphosphate and D-myo-inositol 1,4,5-trisphosphate in milligram quantities from a readily available starting material. Bird IM; Sadler IH; Williams BC; Walker SW Mol Cell Endocrinol; 1989 Oct; 66(2):215-29. PubMed ID: 2558928 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of inositol 1,4,5-trisphosphate metabolism in permeabilised SH-SY5Y human neuroblastoma cells by a phosphorothioate-containing analogue of inositol 1,4,5-trisphosphate. Wojcikiewicz RJ; Cooke AM; Potter BV; Nahorski SR Eur J Biochem; 1990 Sep; 192(2):459-67. PubMed ID: 2209601 [TBL] [Abstract][Full Text] [Related]
33. Evidence for receptor-specific regulation of the metabolism of the second messenger, inositol trisphosphate, in human endothelial cells. Wreggett KA; Irvine RF Biochem Biophys Res Commun; 1993 Jun; 193(3):855-63. PubMed ID: 8391808 [TBL] [Abstract][Full Text] [Related]
35. Development of inositol-based antagonists for the D-myo-inositol 1,4,5-trisphosphate receptor. Keddie NS; Ye Y; Aslam T; Luyten T; Bello D; Garnham C; Bultynck G; Galione A; Conway SJ Chem Commun (Camb); 2011 Jan; 47(1):242-4. PubMed ID: 20938532 [TBL] [Abstract][Full Text] [Related]
36. The separation of myo-inositol phosphates by ion-pair chromatography. Shayman JA; BeMent DM Biochem Biophys Res Commun; 1988 Feb; 151(1):114-22. PubMed ID: 3258151 [TBL] [Abstract][Full Text] [Related]
37. Inositol 1,3,4,5,6-pentakisphosphate and inositol hexakisphosphate are inhibitors of the soluble inositol 1,3,4,5-tetrakisphosphate 3-phosphatase and the inositol 1,4,5-trisphosphate/1,3,4,5-tetrakisphosphate 5-phosphatase from pig brain. Höer A; Oberdisse E Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):219-24. PubMed ID: 1652939 [TBL] [Abstract][Full Text] [Related]
38. myo-Inositol 1,4,5,6-tetrakisphosphate and myo-inositol 3,4,5,6-tetrakisphosphate, two second messengers that may act as pH-dependent molecular switches. Blum-Held C; Bernard P; Schlewer G; Spiess B J Am Chem Soc; 2001 Apr; 123(14):3399-400. PubMed ID: 11457089 [No Abstract] [Full Text] [Related]
39. Phosphorylation of inositol 1,4,5-trisphosphate analogues by 3-kinase and dephosphorylation of inositol 1,3,4,5-tetrakisphosphate analogues by 5-phosphatase. Van Dijken P; Lammers AA; Ozaki S; Potter BV; Erneux C; Van Haastert PJ Eur J Biochem; 1994 Dec; 226(2):561-6. PubMed ID: 8001571 [TBL] [Abstract][Full Text] [Related]
40. Inositol phosphates and inositol phospholipids: how big is the iceberg? Woodcock EA Mol Cell Endocrinol; 1997 Mar; 127(1):1-10. PubMed ID: 9099895 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]